Statement from the ASHM COVID-19 Taskforce regarding the prioritisation of COVID-19 vaccines for people living with blood-borne virus-related chronic liver disease (Record no. 2606)

MARC details
000 -LEADER
fixed length control field	01219nam a22002297a 4500
005 - DATE AND TIME OF LATEST TRANSACTION
Date and Time of Latest Transaction	20231117135540.0
110 ## - MAIN ENTRY--CORPORATE NAME
Main entry -Corporate name in direct order	Taskforce on BBVs, Sexual Health & COVID-19
245 ## - TITLE
Title	Statement from the ASHM COVID-19 Taskforce regarding the prioritisation of COVID-19 vaccines for people living with blood-borne virus-related chronic liver disease
257 ## - COUNTRY OF ORIGIN
Country of origin	Australia
264 ## - PUBLICATION
Place of publication	Sydney
Name of publisher	Aust Society for HIV, Viral Hep & Sexual Health Medicine (ASHM)
Date of publication	2021
300 ## - PHYSICAL DESCRIPTION
Physical description	21p.
520 ## - SUMMARY, ETC.
Content notes:	Designed to provide available, relevant information to clinicians and other healthcare providers to optimise the health and wellbeing of people living with BBV related chronic liver disease during the COVID-19 pandemic.<br/><br/>Related term: Coronavirus
546 ## - LANGUAGE
Language	English
653 ## - SUBJECT
Subject	Transmission: Prevention/infection control
653 ## - SUBJECT
Subject	General reference: Other communicable diseases
856 ## - Web Address
URL	https://ashm.org.au/wp-content/uploads/2023/10/Final-Priority-Vaccine-Statement-People-Living-With-Viral-Hep-V8-March-11.pdf
Link text	Direct link to PDF
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Item type	Online book/report

Holdings
Withdrawn status	Lost status	Source of classification or shelving scheme	Damaged status	Loan status	Home library	Current library	Shelving location	Date acquired	Total Checkouts	Date last seen	Price effective from	Koha item type
		Other/Generic Classification Scheme		Available	Library	Library	Online	18/03/2021		18/03/2021	18/03/2021	Online book/report